Endoperspectives, Volume 5, Issue 3

نویسنده

  • Camilo Jimenez Vasquez
چکیده

The World Health Organization defines pheochromocytoma (PHEO) as a tumor arising from the adrenal medulla and paraganglioma (PGL) as a tumor arising from the paraganglia outside the adrenal medulla. PGLs are located in the head, neck, thorax, abdomen, and pelvis, and can be classified as parasympathetic and sympathetic depending on their origin. Parasympathetic PGLs are mainly located in the head and neck; these tumors may be locally invasive but rarely develop metastases and are not discussed here. Approximately 10-17% of PHEO/PGLs are metastatic. Treatment against metastatic disease includes systemic chemotherapy and radiopharmaceutical agents that are mostly nonspecific and indiscriminately target dividing cells. Patients with metastatic tumors have high morbidity and mortality rates from excessive catecholamine secretion, cardiovascular complications, and bulky disease, for which no curative treatment is available. The 5-year overall survival rate for patients with metastatic tumors ranges is approximately 50%. However, over the last decade our understanding of the genetic and molecular causes of PHEO/PGL has markedly improved. Up to 50% of metastatic cases could be associated with hereditary germline mutations. Additionally, many sporadic metastatic PHEO/PGLs share a similar molecular profile with hereditary tumors. This knowledge is now leading to the development of new therapies based on the molecular mechanisms involved in the formation of malignant PHEO/PGLs. In this review, we will describe clinical predictors of malignancy that could determine the aggressiveness of follow-up and treatment and our current systemic therapeutic approaches for patients with unresectable disease.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Endoperspectives, Volume 3, Issue 2

Hereditary medullary thyroid carcinoma (MTC) presents within the context of 3 genetic syndromes. Multiple endocrine neoplasia type 2A (MEN2A, Sipple’s syndrome) is an autosomal-dominant genetic syndrome that includes MTC, pheochromocytoma, and primary hyperparathyroidism (PHPT). MEN2B is an autosomal-dominant genetic syndrome that includes MTC, pheochromocytoma, multiple mucosal neuromas, and a...

متن کامل

ScienceDirect - Journal of Chromatography A, Volume 1132, Issues 1-2, Pages 1-344 (3 November 2006)

Articles in Press Volumes 1141 1148 (2007) Volumes 1131 1140 (2006 2007) Volume 1140, Issues 1-2 pp. 1-238 (26 January 2007) Volume 1139, Issue 2 pp. 157-310 (19 January 2007) Volume 1139, Issue 1 pp. 1-156 (12 January 2007) Volume 1138, Issues 1-2 pp. 1-310 (5 January 2007) Volume 1137, Issue 2 pp. 127-264 (29 December 2006) Volume 1137, Issue 1 pp. 1-126 (22 December 2006) Volume 1136, Issue ...

متن کامل

On the Performance of Cooperative Spectrum Sensing of Cognitive Radio Networks in AWGN and Rayleigh Fading Environments

| PDF (1174 Kbytes) ■ Sub-channel Allocation Based on Multi-level Priority in OFDMA Systems 1876 1889 JongChan Lee, MoonHo Lee Abstract | PDF (562 Kbytes) ■ Robust Backup Path Selection in Overlay Routing with Bloom Filters 1890 1910 http://www.itiis.org/tiis/content_view_articles.jsp?vol=0&userid= 1 -> 3 08.09.2013 13:58 Xiaolei Zhou, Deke Guo, Tao Chen and Xueshan Luo Abstract | PDF (1483 Kby...

متن کامل

Endoperspectives, Volume 4, Issue 3

Thyroid nodules are a common problem found in up to two-thirds of the population on ultrasound examination. Nodules are often encountered incidentally on exams performed for other purposes. The prevalence increases with age and with radiation exposure and is higher amongst women. Approximately 5-15% of nodules are malignant; therefore, deciphering which nodules warrant attention is important. F...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012